Moclobemide

Also known as: Aurorix, Manerix, Moclamine, Ro 11-1163, p-Chloro-N-(2-morpholinoethyl)benzamide, 4-Chloro-N-[2-(4-morpholinyl)ethyl]benzamide, 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide, Benzamide, 4-chloro-N-[2-(4-morpholinyl)ethyl]-

Moclobemide (CAS 71320-77-9) is a compound in the Organic Bases category listed in the Jingsj chemical database. It has the molecular formula C13H17ClN2O2 and a molecular weight of 268.739 g/mol. Key properties include a melting point of 137°C, a boiling point of 447.7±40.0 °C at 760 mmHg, a density of 1.2±0.1 g/cm3 and a flash point of 224.6±27.3 °C. It is classified under GHS with signal word Danger and hazard statements H302 — Harmful if swallowed, H315 — Causes skin irritation and H318 — Causes serious eye damage. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 71320-77-9
Jingsj CID: J-11423-8
Molecular Formula: C₁₃H₁₇ClN₂O₂
Molecular Weight: 268.739 g/mol
Category: Organic Bases
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	137°C
Boiling Point	447.7±40.0 °C at 760 mmHg
Density	1.2±0.1 g/cm3
Flash Point	224.6±27.3 °C
Exact Mass	268.097870
PSA	41.57000
LogP	0.84
Vapor Pressure	0.0±1.1 mmHg at 25°C
Refractive Index	1.550
Storage Conditions	Room temp

GHS Safety & Compliance

Corrosion / IrritantSignal word: Danger

H302 — Harmful if swallowed
H315 — Causes skin irritation
H318 — Causes serious eye damage
H335 — May cause respiratory irritation

Activity & Biological Data

Additional Information	[1]. Da Prada, M., et al., Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther, 1989. 248(1): p. 400-14. [2]. Verleye, M., et al., Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes. Brain Res, 2007. 1138: p. 30-8. [3]. Reul, J.M., et al., Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology, 1994. 60(5): p. 509-19.

Additional Information

[1]. Da Prada, M., et al., Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther, 1989. 248(1): p. 400-14. [2]. Verleye, M., et al., Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes. Brain Res, 2007. 1138: p. 30-8. [3]. Reul, J.M., et al., Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology, 1994. 60(5): p. 509-19.

Frequently Asked Questions

What is the CAS number of Moclobemide?

The CAS number of Moclobemide is 71320-77-9.

What are the molecular formula and molecular weight of Moclobemide?

Moclobemide has molecular formula C13H17ClN2O2 and molecular weight 268.739 g/mol.

Is Moclobemide hazardous?

Moclobemide has GHS signal word Danger and hazard statements H302 — Harmful if swallowed; H315 — Causes skin irritation; H318 — Causes serious eye damage.

What are the upstream and downstream products of Moclobemide?

For Moclobemide, Upstream Products: 2-morpholinoethanamine, 4-Bromochlorobenzene, 4-Chlorobenzoic acid.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Moclobemide (CAS 71320-77-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-11423-8 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.